MDGL
MDGL
NASDAQ · Biotechnology

Madrigal Pharmaceuticals Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$445.04
-2.68 (-0.60%)
As of Mar 24, 9:45 PM ET ·
Analyst Consensus
Strong Buy
23
Analysts
High
Coverage
Buy 20 87%
Hold 3 13%
Sell 0 0%
Price Target
Analyst Price Target -73.1% upside
Low Target $78.20
Average Target $119.83
High Target $127.79
Current Price $445.04
Current
$445.04
Target
$119.83
$78.20 $119.83 avg $127.79
Scenario Analysis
Bear Case
$78.20
-82.4%
Low target
Base Case
$119.83
-73.1%
Avg target
Bull Case
$127.79
+-71.3%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$615.00
-27.6% from high
52-Week Low
$265.00
+67.9% from low
50-Day SMA
$526.21
-15.4% vs SMA
200-Day SMA
$421.32
+5.6% vs SMA
RSI (14)
32.6
Neutral
Target vs 52W High
$119.83
-80.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +25.5%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -45.2%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -66.8%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 +3.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -26.5%